Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FYBGX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,712
Award facts
- Contract value 100% obligated
- $1,712.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,712.23 by the Defense Logistics Agency on August 15, 2025. The contract calls for delivery of Xolair 300 mg/2 mL auto-injector vials, a prescription medication used in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria. The delivery order carries an ultimate completion date of September 8, 2025, with the place of performance at DMS Pharmaceutical Group's Park Ridge facility. This award was not issued under a set-aside designation.
This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support the medical supply needs of military healthcare facilities worldwide. As a long-standing federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a key supplier within the Department of Defense pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYBGX?
SPE2DB25FYBGX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FYBGX worth?
The government has obligated $1,712 on SPE2DB25FYBGX.
Is contract SPE2DB25FYBGX an order under another contract?
Yes. SPE2DB25FYBGX is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBGX competed?
The extent of competition for SPE2DB25FYBGX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award